durapatite has been researched along with zoledronic acid in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (12.12) | 29.6817 |
| 2010's | 25 (75.76) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Bobyn, JD; Cohen, R; Karabasz, D; Krygier, JJ; Tanzer, M | 1 |
| Chang, SS; Cho, SK; Gardner, TR; Lee, FY; Park, SH; Seo, SW; Suratwala, SJ; van Raalte, JJ | 1 |
| Gao, Y; Hu, J; Li, J; Luo, E; Xue, J; Zhu, S | 1 |
| Bao, C; Gao, Y; Hu, J; Liu, X; Zou, S | 1 |
| Barnett, BL; Dunford, JE; Ebetino, FH; Lawson, MA; Locklin, RM; Phipps, RJ; Russell, RG; Triffitt, JT; Xia, Z | 1 |
| Gao, Y; Hu, J; Li, Y; Liu, X; Song, G | 1 |
| Henry, C; Jahnke, W | 1 |
| Ferretti, C; Klar, RM; Renton, LF; Ripamonti, U | 1 |
| Dennis Bobyn, J; Karabasz, D; McKenzie, K; Roberts, J; Tanzer, M | 1 |
| Bigi, A; Boanini, E; Fini, M; Gazzano, M; Torricelli, P | 1 |
| Draenert, GF; Huetzen, DO; Kämmerer, PW; Nacu, V; Palarie, V; Wagner, W | 1 |
| Cooper-White, JJ; Fitzpatrick, J; Little, DG; Mikulec, K; Peacock, L; Ruys, AJ; Schindeler, A; Yu, NY | 1 |
| Dong, W; Hu, J; Li, JP; Li, JY; Li, P; Liao, NN; Qi, MC | 1 |
| Guo, X; Lu, X; Ni, B; Shi, J; Xie, N; Zeng, Y; Zhu, M; Zhu, Y | 1 |
| Bigi, A; Boanini, E; Della Bella, E; Fini, M; Gazzano, M; Torricelli, P | 1 |
| Khajuria, DK; Mahapatra, DR; Razdan, R | 1 |
| Hu, J; Li, Y; Shui, X; Zhang, L | 1 |
| Bartoszewicz, M; Gluza, K; Junka, A; Kos, M; Smutnicka, D; Szymczyk, P | 1 |
| Kettenberger, U; Luginbuehl, V; Pioletti, DP; Procter, P | 1 |
| Ghoshal, S; Henderson, W; Jang, SS; Kumar, S; Liu, Y; Niu, LN; Pashley, DH; Pramanik, C; Sood, P; Tay, FR; Yuan, H | 1 |
| Hettwer, W; Isaksson, H; Kumar, A; Lidgren, L; Raina, DB; Tägil, M | 1 |
| Isaksson, H; Kumar, A; Lidgren, L; Raina, DB; Tägil, M; Teotia, AK | 1 |
| Guo, WS; Li, ZR; Ma, JH; Wang, BL | 1 |
| Chen, Z; Kong, D | 1 |
| Borges, LCFS; Chaud, MV; de Almeida, AD; Grotto, D; Hataka, A; Leite, FG; Rebelo, MA; Viroel, FJM | 1 |
| Hu, X; Li, L; Li, M; Lu, Y; Shan, G; Wang, X; Wei, S; Xia, H; Yin, Q; Zhang, Y | 1 |
| Isaksson, H; Kumar, A; Larsson, D; Lidgren, L; Mrkonjic, F; Raina, DB; Tägil, M | 1 |
| Isaksson, H; Kumar, A; Larsson, D; Lidgren, L; Qayoom, I; Raina, DB; Tägil, M; Zheng, MH | 1 |
| Arai, N; Kurohara, K; Kutsuna, T; Murata, T; Shimizu, K; Tomeoku, A | 1 |
| Isaksson, H; Lidgren, L; Liu, Y; Raina, DB; Tägil, M | 1 |
| Isaksson, H; Kumar, A; Lidgren, L; Liu, Y; Qayoom, I; Raina, DB; Širka, A; Tägil, M; Tanner, KE; Tarasevicius, S; Teotia, AK | 1 |
| Bolte, J; Isaksson, H; Lidgren, L; Matuszewski, LM; Raina, DB; Tägil, M; Vater, C; Zwingenberger, S | 1 |
| Choquesillo-Lazarte, D; Demadis, KD; Lazarou, S; Turhanen, P; Vassaki, M | 1 |
33 other study(ies) available for durapatite and zoledronic acid
| Article | Year |
|---|---|
The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution.
Topics: Animals; Bone Density Conservation Agents; Coated Materials, Biocompatible; Diphosphonates; Dogs; Drug Delivery Systems; Durapatite; Imidazoles; Microscopy, Electron, Scanning; Models, Animal; Osseointegration; Prostheses and Implants; Radiography; Tantalum; Ulna; Zoledronic Acid | 2005 |
Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite.
Topics: Animals; Bone Density Conservation Agents; Bone Nails; Coated Materials, Biocompatible; Diphosphonates; Durapatite; Equipment Failure Analysis; Femur; Fracture Fixation, Intramedullary; Imidazoles; Male; Osseointegration; Polyethylenes; Rats; Rats, Sprague-Dawley; Weight-Bearing; Zoledronic Acid | 2008 |
Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats.
Topics: Animals; Biomechanical Phenomena; Diphosphonates; Drug Synergism; Durapatite; Female; Fibroblast Growth Factor 2; Imaging, Three-Dimensional; Imidazoles; Ovariectomy; Prosthesis Implantation; Rats; Rats, Sprague-Dawley; Surface Properties; Tibia; Titanium; X-Ray Microtomography; Zoledronic Acid | 2009 |
The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats.
Topics: Absorptiometry, Photon; Animals; Biomechanical Phenomena; Bone Density; Coated Materials, Biocompatible; Diphosphonates; Durapatite; Female; Ibandronic Acid; Imidazoles; Implants, Experimental; Microscopy, Electron, Scanning; Ovariectomy; Pamidronate; Rats; Rats, Sprague-Dawley; Surface Properties; Tibia; Titanium; X-Ray Microtomography; Zoledronic Acid | 2009 |
Differences between bisphosphonates in binding affinities for hydroxyapatite.
Topics: Bone Density Conservation Agents; Chromatography, Liquid; Diphosphonates; Durapatite; Etidronic Acid; Imidazoles; Risedronic Acid; Spectrophotometry, Ultraviolet; Zoledronic Acid | 2010 |
Additive effects of estrogen replacement therapy and bisphosphonates on osseointegration of hydroxyapatite-coated titanium screws in ovariectomized rats.
Topics: Alloys; Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Bone Screws; Coated Materials, Biocompatible; Dental Alloys; Diphosphonates; Durapatite; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Imidazoles; Injections, Subcutaneous; Osseointegration; Ovariectomy; Rats; Rats, Sprague-Dawley; Shear Strength; Stress, Mechanical; Tibia; Time Factors; Titanium; X-Ray Microtomography; Zoledronic Acid | 2010 |
An in vitro assay to measure targeted drug delivery to bone mineral.
Topics: Alendronate; Anabolic Agents; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Drug Delivery Systems; Durapatite; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Nuclear Magnetic Resonance, Biomolecular; Pamidronate; Risedronic Acid; Zoledronic Acid | 2010 |
Synergistic induction of bone formation by hOP-1, hTGF-beta3 and inhibition by zoledronate in macroporous coral-derived hydroxyapatites.
Topics: Animals; Anthozoa; Bone Density Conservation Agents; Bone Morphogenetic Protein 7; Calcium Carbonate; Diphosphonates; Durapatite; Humans; Imidazoles; Implants, Experimental; Osteogenesis; Papio ursinus; Porosity; Recombinant Proteins; Rectus Abdominis; Transforming Growth Factor beta3; Zoledronic Acid | 2010 |
Bisphosphonate remains highly localized after elution from porous implants.
Topics: Animals; Autoradiography; Bone Density Conservation Agents; Coated Materials, Biocompatible; Diphosphonates; Dogs; Drug Carriers; Durapatite; Femur; Imidazoles; Osteogenesis; Prostheses and Implants; Prosthesis Implantation; Scintillation Counting; Solubility; Tantalum; Zoledronic Acid | 2011 |
The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.
Topics: Alendronate; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diphosphonates; Durapatite; Humans; Imidazoles; Microscopy, Electron, Scanning; Nanocomposites; Nanoparticles; Osteoblasts; Osteoclasts; X-Ray Diffraction; Zoledronic Acid | 2012 |
Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Bone Resorption; Cell Culture Techniques; Cell Line; Cell Shape; Cell Survival; Collagen; Coloring Agents; Cytoprotection; Diphosphonates; Drug Carriers; Durapatite; Female; Fibroblasts; Fluoresceins; Fluorescent Dyes; Gingiva; Humans; Imidazoles; Models, Animal; Osteoblasts; Osteogenesis; Protective Agents; Rabbits; Razoxane; Tetrazolium Salts; Thiazoles; Tibia; Zoledronic Acid | 2012 |
Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Compressive Strength; Diphosphonates; Durapatite; Female; Imidazoles; Implants, Experimental; Lactic Acid; Mice; Mice, Inbred C57BL; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity; Radiography; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; Zoledronic Acid | 2013 |
Early healing of hydroxyapatite-coated implants in grafted bone of zoledronic acid-treated osteoporotic rabbits.
Topics: Absorptiometry, Photon; Animals; Autografts; Bone Density; Bone Density Conservation Agents; Bone Transplantation; Calcification, Physiologic; Coated Materials, Biocompatible; Dental Implants; Diphosphonates; Durapatite; Female; Ilium; Imidazoles; Osseointegration; Osteoporosis; Ovariectomy; Rabbits; Stress, Mechanical; Tibia; Time Factors; Torque; Transplant Donor Site; Wound Healing; X-Ray Microtomography; Zoledronic Acid | 2014 |
Mesoporous silica nanoparticles/hydroxyapatite composite coated implants to locally inhibit osteoclastic activity.
Topics: Animals; Bone Resorption; Bone Wires; Coated Materials, Biocompatible; Diphosphonates; Drug Carriers; Durapatite; Humans; Imidazoles; Nanoparticles; Osteoclasts; Porosity; Prostheses and Implants; Silicon Dioxide; Zoledronic Acid | 2014 |
Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coculture Techniques; Diphosphonates; Durapatite; Humans; Imidazoles; Nanoparticles; Osteoblasts; Osteocytes; Strontium; Zoledronic Acid | 2014 |
Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model.
Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relationship, Drug; Durapatite; Female; Imidazoles; Nanoparticles; Osteoporosis; Ovariectomy; Random Allocation; Rats; Zoledronic Acid | 2015 |
Cancellous bone healing around strontium-doped hydroxyapatite in osteoporotic rats previously treated with zoledronic acid.
Topics: Animals; Cancellous Bone; Diphosphonates; Durapatite; Female; Femoral Fractures; Fracture Healing; Imidazoles; Osteoporosis; Rats; Rats, Sprague-Dawley; Strontium; Zoledronic Acid | 2016 |
Bisphosphonates enhance bacterial adhesion and biofilm formation on bone hydroxyapatite.
Topics: Bacterial Adhesion; Bacteriological Techniques; Biocompatible Materials; Biofilms; Bone and Bones; Bone Density Conservation Agents; Clodronic Acid; Coated Materials, Biocompatible; Diphosphonates; Durapatite; Humans; Hydrogen Bonding; Imidazoles; Microscopy, Electron, Scanning; Pamidronate; Pseudomonas aeruginosa; Staphylococcus aureus; Static Electricity; Streptococcus mutans; X-Ray Microtomography; Zoledronic Acid | 2015 |
In vitro and in vivo investigation of bisphosphonate-loaded hydroxyapatite particles for peri-implant bone augmentation.
Topics: Animals; Bone Substitutes; Diphosphonates; Disease Models, Animal; Durapatite; Female; Femur; Humans; Imidazoles; Mice; Osteoporosis, Postmenopausal; Rats; Rats, Wistar; RAW 264.7 Cells; Zoledronic Acid | 2017 |
A mechanistic study of the interaction of water-soluble borate glass with apatite-bound heterocyclic nitrogen-containing bisphosphonates.
Topics: Apatites; Bone and Bones; Borates; Calcification, Physiologic; Cations; Computer Simulation; Diphosphonates; Durapatite; Glass; Humans; Imidazoles; Ions; Jaw; Magnesium; Magnetic Resonance Spectroscopy; Nitrogen; Osteonecrosis; Protons; Solubility; Water; X-Ray Diffraction; Zoledronic Acid | 2016 |
A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Calcium Sulfate; Diphosphonates; Drug Carriers; Durapatite; Imidazoles; Microscopy, Electron, Scanning; Models, Animal; Osteogenesis; Rats; Recombinant Proteins; Zoledronic Acid | 2016 |
Biocomposite macroporous cryogels as potential carrier scaffolds for bone active agents augmenting bone regeneration.
Topics: Alkaline Phosphatase; Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Line; Cell Proliferation; Chitosan; Cryogels; Diphosphonates; Drug Carriers; Durapatite; Fibroins; Glass; Imidazoles; Male; Mice; Osteogenesis; Porosity; Rats, Sprague-Dawley; Recombinant Proteins; Sepharose; Zoledronic Acid | 2016 |
Local Administration of Bisphosphonate-soaked Hydroxyapatite for the Treatment of Osteonecrosis of the Femoral Head in Rabbit.
Topics: Animals; Diphosphonates; Durapatite; Female; Femur Head Necrosis; Imidazoles; Immunohistochemistry; Male; Zoledronic Acid | 2016 |
Evaluation of the interaction between hydroxyapatite and bisphosphonate by nonlinear capillary electrochromatography.
Topics: Bone and Bones; Capillary Electrochromatography; Diphosphonates; Durapatite; Imidazoles; Zoledronic Acid | 2017 |
Safety and efficacy of hydroxyapatite scaffold in the prevention of jaw osteonecrosis in vivo.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Disease Models, Animal; Durapatite; Male; Rats; Rats, Wistar; Tissue Scaffolds; Tooth Extraction; Zoledronic Acid | 2018 |
High-activity chitosan/nano hydroxyapatite/zoledronic acid scaffolds for simultaneous tumor inhibition, bone repair and infection eradication.
Topics: Apoptosis; Biocompatible Materials; Bone Regeneration; Bone Substitutes; Cells, Cultured; Chitosan; Coculture Techniques; Diphosphonates; Durapatite; Erythrocytes; Escherichia coli; Hemolysis; Humans; Imidazoles; Mesenchymal Stem Cells; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanocomposites; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Tissue Engineering; Tissue Scaffolds; Zoledronic Acid | 2018 |
Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
Topics: Animals; Biocompatible Materials; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Calcium Sulfate; Cell Line; Cell Survival; Delayed-Action Preparations; Durapatite; Gelatin; Male; Mice; Osteogenesis; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta; Zoledronic Acid | 2018 |
Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
Topics: Animals; Biocompatible Materials; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Sulfate; Collagen; Drug Delivery Systems; Durapatite; Gelatin; Male; Rats, Sprague-Dawley; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; Zoledronic Acid | 2019 |
Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Durapatite; Humans; MCF-7 Cells; Mouth Neoplasms; Nanoparticles; Zoledronic Acid | 2018 |
Synthetic hydroxyapatite: a recruiting platform for biologically active molecules.
Topics: Animals; Anti-Bacterial Agents; Bone Density Conservation Agents; Coated Materials, Biocompatible; Drug Carriers; Drug Delivery Systems; Durapatite; Fluorides; Implants, Experimental; Male; Particle Size; Positron Emission Tomography Computed Tomography; Rats, Sprague-Dawley; Tetracycline; Zoledronic Acid | 2020 |
Long-Term Response to a Bioactive Biphasic Biomaterial in the Femoral Neck of Osteoporotic Rats.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Calcium Sulfate; Durapatite; Femur Neck; Humans; Osteoporosis; Rats; Recombinant Proteins; Tissue Engineering; Zoledronic Acid | 2020 |
A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein-2 and zoledronic acid.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Calcium Sulfate; Durapatite; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfates; Zoledronic Acid | 2020 |
Drug-Inclusive Inorganic-Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate.
Topics: Bone Density Conservation Agents; Calcium; Delayed-Action Preparations; Diphosphonates; Durapatite; Humans; Imidazoles; Osteoporosis; Zoledronic Acid | 2022 |